PROCHYMAL

allogeneic mesenchymal stem cells · Mesoblast, Inc.

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for PROCHYMAL, covering 2020-04-02 to 2026-03-11. Get the full timeline:

Most recent: Clinical Trial Update: PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM) [Phase 2]

See pricing